Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients

• Published in: BMC pulmonary medicine Vol. 20; no. 1; p. 89
• Main Authors: Yu, Qihong, He, Jingdong, Xing, Bin, Li, Xin, Qian, Hongyu, Zhang, Hong, Xu, Meilin, Peng, Haiying
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 15-04-2020; BioMed Central; BMC
• Subjects: Aged; Antibiotics; Antibodies, Fungal - blood; Antigens; Aspergillosis; Aspergillus; Aspergillus - immunology; Bacteria; Biomarkers - blood; Biotechnology; Chronic Disease; Chronic illnesses; Chronic infection; Diagnosis; Disease; Enzyme-Linked Immunosorbent Assay; Enzymes; Female; Fungal infections; Health aspects; Humans; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin M; Infections; Invasive Pulmonary Aspergillosis - blood; Invasive Pulmonary Aspergillosis - diagnosis; Male; Mannans - blood; Medical diagnosis; Middle Aged; Mortality; Non-agranulocytic patients; Pneumonia; Pulmonary aspergillosis; Pulmonology; ROC Curve; Sensitivity and Specificity; Serum Aspergillus IgG; Statistical analysis; China; Serum Aspergillus IgG; Diagnosis; Non-agranulocytic patients; Pulmonary aspergillosis
• ISSN: 1471-2466; 1471-2466
• DOI: 10.1186/s12890-020-1125-y

At present, serum Aspergillus IgG and IgM antibody detection is mainly used in the diagnosis of chronic pulmonary aspergillosis (CPA), but its value in the diagnosis of invasive pulmonary aspergillosis (IPA) in non-agranulocytic patients is still unclear. IgM can be used as a marker of acute infection to help diagnose acute infection-related diseases. IgG is a marker of long-term infection and is used to assist in the diagnosis of pre-existing or chronic infection-related diseases. The aim of this study was to investigate and compare the value of serum Aspergillus IgG and IgM antibody detection in the diagnosis of IPA and CPA in non-agranulocytic patients.
Fifty-eight cases of pulmonary aspergillosis (37 IPA and 21 CPA cases), 15 cases of community-acquired bacterial pneumonia and 50 cases in the healthy control group were collected. The serum (1,3)-β-D-glucan test (G test) was performed with a chromogenic method, and the galactomannan test (GM test) and Aspergillus IgG and IgM antibody detection were performed by commercial enzyme-linked immunosorbent assay (ELISA) in all patients. The sensitivity and specificity, cut-off value and area under the curve (AUC) of Aspergillus IgG and IgM antibodies were further obtained by receiver operating characteristic (ROC) curves.
The positive rate of the G test, Aspergillus IgG antibody detection and the GM test also showed notable differences among the IPA, CPA, community-acquired bacterial pneumonia and healthy groups (P = 0.006, P <  0.001 and P = 0.217, respectively). Only the positive rate of the GM test showed a significant difference between the IPA and CPA groups (P = 0.04). ROC curves indicated that Aspergillus IgG antibody detection had a higher specificity in the IPA group than in the CPA group (0.952). The detection of Aspergillus IgG antibody can preferably distinguish IPA from community-acquired bacterial pneumonia and healthy controls (sensitivity = 0.923, specificity = 0.459, cut-off value = 134.46, AUC = 0.727). It can also distinguish CPA from community-acquired bacterial pneumonia and healthy controls (sensitivity = 0.952, specificity = 0.692, cut-off value = 75.46, AUC = 0.873).
Serum Aspergillus IgG antibody detection may have certain clinical value in the diagnosis of IPA and CPA in non-agranulocytic patients.